RGEN
Repligen Corp
Price:  
141.51 
USD
Volume:  
581,931.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN WACC - Weighted Average Cost of Capital

The WACC of Repligen Corp (RGEN) is 7.7%.

The Cost of Equity of Repligen Corp (RGEN) is 7.85%.
The Cost of Debt of Repligen Corp (RGEN) is 5.50%.

Range Selected
Cost of equity 6.60% - 9.10% 7.85%
Tax rate 11.30% - 15.70% 13.50%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.4% - 8.9% 7.7%
WACC

RGEN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.6 0.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 9.10%
Tax rate 11.30% 15.70%
Debt/Equity ratio 0.07 0.07
Cost of debt 4.00% 7.00%
After-tax WACC 6.4% 8.9%
Selected WACC 7.7%

RGEN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for RGEN:

cost_of_equity (7.85%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.6) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.